Technology company Health Connect Global has launched a study into AI-assisted care planning.
The study will assess the AI tool against three measures: how clinically accurate its care plans are; how person-centred they are; and how efficiently it can produce high-quality plans. It forms part of the company’s registration process with the Medicines and Healthcare products Regulatory Agency.
Participants will be given a set of care plans, some written by care professionals and some generated by the AI tool, without being told which is which. Each plan is then scored against a defined matrix based on the participant’s own clinical judgement.
Writing and reviewing care plans can be time-consuming. Research by Health Connect Global found social care staff spend between 15 and 20 hours each week on manual administration and compliance tasks. The tool draws on available patient data to help clinicians structure comprehensive, individualised plans in line with clinical guidelines, with professionals keeping responsibility for every decision about a person’s care.
To make sure the study is run fairly and ethically, Health Connect Global has set up an independent expert panel whose members have senior experience at Department of Health and Social Care, the Care Quality Commission, psychiatry, frontline social care, national workforce strategy, and AI health research.
Co-chairing the panel is the Steve Barclay MP, who served as secretary of state for health and social care. Alongside him as co-chair is Phoebe Reynolds, divisional lead for social care in Greater Manchester. Other panel members include Professor Martin Green, chief executive of Care England, Dr Jane Brightman, director of workforce strategy at Skills for Care, and Deborah Rozansky, director policy, research and information at the Social Care Institute for Excellence.
‘We need to have AI that is properly tested and trusted in care. That is why we have opened our tool up to blind testing by care workers across the country. The breadth and pedigree of the volunteer panel overseeing this is in itself extraordinary and sets an example of the type of collaboration that is needed to improve care safely at scale,’ said Devan Moodley, CEO and founder of Health Connect Global.
Barclay said: ‘As health secretary, I saw how AI could speed up diagnosis and free up clinicians’ time across the NHS. Social care deserves the same opportunity. The sector carries a heavy administrative burden, and every hour spent on paperwork is an hour taken away from caring for people. For care providers to adopt AI with confidence, they need evidence they can trust. A blinded study, tested by those who will use the tool, and scrutinised by an independent panel, is the right way to build that evidence, and I am pleased to be a part of this.’
For more on the blind test click here.

©2026 All rights reserved LaingBuisson

